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ABSTRACT 
Myosin A (MyoA) is a Class XIV myosin 
implicated in gliding motility and host cell and 
tissue invasion by malaria parasites. MyoA is 
part of a membrane-associated protein 
complex called the glideosome, which is 
essential for parasite motility and includes the 
MyoA light chain MTIP, and several 
glideosome-associated proteins (GAPs). 
However, most studies of MyoA have focused 
on single stages of the parasite life cycle. We 
examined MyoA expression throughout the 
Plasmodium berghei life cycle in both 
mammalian and insect hosts. In extracellular 
ookinetes, sporozoites and merozoites, MyoA 
was located at the parasite periphery. In the 
sexual stages, zygote formation and initial 
ookinete differentiation precede MyoA 
synthesis and deposition, which occurred only 
in the developing protuberance. In developing 
intracellular asexual blood stages, MyoA was 
synthesized in mature schizonts and was 
located at the periphery of segmenting 
merozoites, where it remained throughout 
maturation, merozoite egress and host cell 
invasion. Besides the known GAPs in the 
malaria parasite, the complex included 
GAP40, an additional myosin light chain 
designated essential light chain (ELC) and 
several other candidate components. This ELC 
bound the MyoA neck region adjacent to the 
MTIP binding site, and both myosin light 
chains co-located to the glideosome. Co-
expression of MyoA with its two light chains 
revealed that the presence of both light chains 
enhances MyoA-dependent actin motility. In 
conclusion, we have established a system to 
study the interplay and function of the three 
glideosome components, enabling the 
assessment of inhibitors that target this motor 
complex to block host cell invasion. 
 
The abbreviations used are:  
ABC, ammonium bicarbonate; ACN, 
acetonitrile; CTD, C-terminal domain; ELC, 
essential light chain; GAP, glideosome 
associated protein; IFA, indirect 
immunofluorescence assay; IMC, inner 
membrane complex; IPTG, Isopropyl β-D-1-
thiogalactopyranoside; MLC-B, myosin B 
light chain; Myo, myosin; MTIP, myosin tail 
domain interacting protein; PV, 
parasitophorous vacuole; PVM, 
parasitophorous vacuole membrane; TCEP, 
tris(2-carboxyethyl)phosphine;  
____________________________________ 
Three stages of the malaria parasite, 
sporozoites, ookinetes and merozoites, are 
invasive to host cells or tissue and two stages, 
sporozoites and ookinetes, are motile. Motility 
and invasion are active processes and in 
Plasmodium as in other apicomplexan 
parasites such as Toxoplasma gondii (Tg), an 
actomyosin motor is central to these processes 
(reviewed in (1, 2)). Myosin proteins are 
typically composed of a conserved globular 
head domain, a neck domain comprising 
variable numbers of myosin light chain 
binding sites, and a diverse tail domain that is 
often responsible for dimerization and/or cargo 
binding. The myosin head binds to actin and 
also contains the motor activity, where ATP 
hydrolysis is translated into molecular 
movement (3-6). Myosin A (MyoA), an 
Apicomplexa-specific class XIV myosin 
comprised of a head and neck region, but 
lacking a tail domain, is the motor component 
of the glideosome protein complex is attached 
to the inner membrane complex (IMC), a 
network of large, flattened vesicles located just 
below the surface plasma membrane of the 
parasite (7-9).  
Some components of the glideosome 
have been defined in T. gondii and also in 
Plasmodium species. In addition to MyoA, 
there is a myosin light chain (MLC) that binds 
to the last few amino acid residues of MyoA, 
corresponding to part of the myosin neck 
region and called T. gondii MLC1 (10), or 
myosin tail domain interacting protein (MTIP) 
in Plasmodium spp. (11). This MLC is 
involved in anchoring MyoA to the IMC via a 
palmitoyl modification (12) and thus appears 
to take on a role usually fulfilled by a myosin 
tail, that is anchoring myosin at a specific 
subcellular location. Recently, two more T. 
gondii MyoA MLCs have been described and 
called essential light chains (ELC) 1 and 2. 
The terminology follows that used for 
mammalian muscle myosins with two light 
chains in which the most proximal is an ELC 
and the distal is a regulatory light chain 
(RLC). ELC1 and 2 have been shown to bind 
to the MyoA neck adjacent to MLC1 (which 
binds at the RLC site) in a mutually exclusive 
manner and are important for motor activity 
(13, 14). Bookwalter and colleagues have 
demonstrated that a heterologously expressed 
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TgMyoA requires both MLC1 and an ELC in 
order to move actin at its fastest speed (15). In 
addition to MyoA and its associated light 
chains, a number of glideosome-associated 
proteins (GAPs) have been described, 
including GAP45 (16-18) (and its Coccidia-
specific homolog GAP70 (19)), GAP50  and a 
family of three proteins with multiple 
membrane spans known as GAPMs (20). 
Another glideosome component, GAP40, has 
been described in T. gondii (19) and has a 
homologue in Plasmodium based on genomic 
(21) and proteomic studies (22-24), but it has 
not been shown experimentally to be part of 
the glideosome in this genus. In Plasmodium, 
most studies on MyoA have been limited to 
the asexual blood stage parasites in the 
mammalian host, although its essential role in 
gliding motility in P. berghei ookinetes has 
been demonstrated in promoter swap 
experiments (25). 
In this study, we have examined the 
expression and location of MyoA throughout 
the malaria parasite life cycle, including all 
invasive stages, and its temporal profile during 
merozoite and ookinete development. We have 
examined the composition of the glideosome 
in asexual blood stages by 
immunoprecipitation and mass spectrometry of 
proteins associated with GFP-tagged MyoA, 
confirming the presence of GAP40 and 
identifying a new myosin light chain. This 
essential-type light chain binds to the MyoA 
neck adjacent to, and in addition to, MTIP. 
Recombinant PfMyoA binds actin and with 
both light chains bound demonstrates 
increased sliding velocity of actin compared to 
MyoA with just MTIP bound. This is a first 
important step to reconstituting the 
Plasmodium glideosome in vitro, which will 
be an invaluable system with which to dissect 
the function of, and interplay between, 
different components of the complex. 
 
RESULTS 
Myosin A is a predominantly membrane-
associated protein at the periphery of all 
invasive stages of the P. berghei life cycle 
Expression of the myoA gene was detected by 
qRT-PCR throughout the parasite life cycle, 
particularly in schizonts and sporozoites, but 
also in non-activated gametocytes (Fig. 1A). 
To examine the synthesis and location of the 
protein throughout the parasite life cycle we 
produced a C-terminal green fluorescent 
protein (GFP)-tagged MyoA expressed from 
the endogenous genomic locus using a strategy 
we described recently for P. falciparum MyoA 
and P. berghei MyoB (26) (Fig. 1B). 
Integration of sequence coding for GFP into 
the endogenous MyoA locus and expression of 
the tagged protein was confirmed by PCR 
amplification from genomic DNA using 
primers that only produce a product following 
specific integration (Fig. 1C), by western 
blotting (Fig. 1D), and by fluorescence 
microscopy (Fig. 1F-H). Tagging MyoA with 
GFP resulted in no detectable phenotype: there 
was no effect on the rate of asexual parasite 
growth, on male gametogenesis (the number of 
exflagellation centres), the number of oocysts 
per mosquito gut or the efficiency of infection 
via sporozoite inoculation (as judged by the 
number of days following infected mosquito 
bite that parasites were observed by 
microscopy in blood smears). In a subcellular 
fractionation of schizonts, the protein was 
largely associated with the peripheral 
membrane (carbonate soluble) and membrane 
(carbonate insoluble) fractions rather than in 
the soluble cell lysate (Fig. 1E), consistent 
with its association with the glideosome and 
the IMC membrane compartments. Using live 
parasite microscopy, the protein was detected 
uniformly at the periphery of segmenting 
schizonts and extracellular merozoites in 
asexual blood stages and at a similar location 
in extracellular ookinetes and salivary gland 
sporozoites (Fig. 1F), consistent with location 
at the IMC. Interestingly, in sporozoites there 
was also a clear perinuclear localization. In 
early cytomere stages of liver-stage schizonts 
the signal appeared to be cytosolic, rather than 
membrane associated. In late cytomere stages, 
55 h after invasion by sporozoites, a clear 
peripheral location associated with the hepatic 
merozoites was observed (Fig. 1G). The 
presence of myoA mRNA in ookinete stages, 
as well as in non-activated gametocytes as a 
translationally repressed transcript, prompted 
us to examine the temporal profile of protein 
expression during the 24 hours of ookinete 
development divided into six stages (27) (Fig. 
1H). MyoA-GFP was not visible in either 
activated or non-activated gametocytes and 
barely detectable in the zygote and stage I and 
II ookinetes. Following the establishment of 
morphological polarity at about 10 hours after 
fertilization (Stage III) the protein was 
detectable in the growing protuberance rather 
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than the spherical body in the intermediate 
retort forms, so-called because of their shape 
(stages III–V). This location was retained in 
later stages, with the MyoA-GFP associated 
with the parasite periphery in fully formed 
motile ookinetes. There was a concentration of 
fluorescence detected at the apical tip of the 
mature ookinete. Immunofluorescence using 
an antibody against the surface marker P28 
was used to visualize the ookinete at all stages 
of development. 
 
Expression of MyoA during P. falciparum 
asexual blood stage development and 
formation of the glideosome complex  
The use of P. falciparum allows a more 
detailed analysis of asexual blood stages than 
can be achieved with P. berghei. MyoA-GFP 
was largely undetectable by live fluorescence 
microscopy until approximately 38 hours after 
merozoite invasion of an erythrocyte, but was 
present in later stages at the periphery of 
developing segmented schizonts and free 
merozoites (but not associated with the food 
vacuole/residual body), consistent with its 
proposed location at the IMC (Fig. 2A). No 
GFP signal was detected in ring or trophozoite 
stages indicating that the protein is not 
synthesised at this time and any MyoA carried 
through with the invading merozoite is 
degraded rapidly following erythrocyte 
invasion. Interestingly, the protein was also 
not detected in early schizonts when the first 
formation of the IMC can already be detected 
with, for example GFP-tagged GAP50 (28) or 
GAP45 (29) and seen as small ring-shaped 
structures at the tips of developing merozoites. 
Western blot analysis of parasite extracts at the 
corresponding time points (Fig. 2Bi) 
confirmed that GAP50 is present in early 
schizonts (detectable from 24 h and strongly 
expressed 30 h post-invasion). Whilst a small 
amount of MyoA-GFP can be detected 27–
36 h after merozoite invasion, the strongest 
expression is detected from 38 h post-invasion. 
A western blot analysis of the MyoA-GFP 
immunoprecipitate obtained from these 
extracts (Fig. 2Bii) indicates that known 
components of the glideosome complex, 
MTIP, GAP45 and GAP50 are associated with 
MyoA from 38 h after erythrocyte invasion by 
a merozoite. Tagging MyoA with GFP had no 
effect on the rate of asexual blood stage 
parasite growth.  
 
Location of MyoA in P. falciparum during 
erythrocyte invasion 
The peripheral location of MyoA-GFP in 
mature schizonts and free merozoites was 
confirmed by indirect immunofluorescence 
assay (Fig. 3A). Antibodies against GFP co-
localised with antibodies against MTIP, 
GAP45 and GAP50 consistent with the 
presence of these proteins in a complex. 
During erythrocyte invasion, the peripheral 
location of MyoA did not change during the 
transition from initial attachment of the 
merozoite to the intracellular ring stage at the 
completion of invasion (Fig. 3B). However, 
thereafter the signal disappeared until 
resynthesis during schizogony. 
 
Identification of GAP40 and discovery of a 
second MyoA light chain in the P. falciparum 
glideosome complex 
A number of proteins associated with the 
glideosome have been identified in both 
Plasmodium and Toxoplasma species and the 
presence of GAP45, GAP50, and MTIP, some 
of the known components in P. falciparum 
asexual blood stages, has been confirmed 
above. To examine what other proteins might 
be associated we examined further the protein 
complex immunoprecipitated with GFP-
specific antibodies. To do this we first used 
parasites in which GAP45 was tagged 
internally with GFP (29) and then those in 
which MyoA was tagged at its C-terminus 
with GFP. In the first instance we were 
interested to see whether or not GAP40, which 
is a highly phosphorylated protein (23, 30-32) 
present in the T. gondii glideosome (19), is 
present in the Plasmodium complex. In order 
to visualise phosphorylated proteins associated 
with GFP-GAP45 we metabolically labelled P. 
falciparum schizont phosphoproteins using 
32P-phosphate (Fig. 4). As a control, 3D7 
schizonts in which GAP45 was unmodified 
were used (Fig. 4, lane 1 in panels A and B). 
The glideosome was precipitated from 
schizont lysates using antibodies to GFP, and 
32P-labelled phosphoproteins were visualised 
by autoradiography (Fig. 4A). In addition to 
GFP-GAP45 itself, there were five labelled 
proteins that were absent from the control 
samples. The identities of some were 
confirmed by immunoprecipitation from 
schizont lysates with GFP antibodies followed 
by western blotting with antibodies against 
known glideosome components MyoA, 
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GAP45, GAP50, and MTIP (Fig. 4A). The 
most prominent of the phosphoproteins, with 
an apparent molecular weight of just under 
50 kDa, was distinct from these four proteins 
and so its identity was examined further by 
mass spectroscopy following fractionation of 
the protein precipitate by SDS-PAGE and 
tryptic digestion of specific bands (Fig. 4B and 
C). This analysis clearly identified the protein 
as GAP40 and confirmed the presence of 
GAP45 and GAP50 in the immunoprecipitate. 
The high molecular weight phosphoprotein, 
marked with an asterisk in Fig. 4A, was not 
detected in the SYPRO Ruby stained 
immunoprecipitate. High level 
phosphorylation of a low abundance protein is 
one possible explanation for this discrepancy.  
An immunoprecipitate from parasites 
expressing GFP-tagged MyoA was also 
analysed by tryptic digestion, with LC-MS/MS 
analysis of resultant peptides in order to 
identify associated proteins. Again, 3D7 
schizonts in which MyoA was unmodified 
were used as a negative control. Table 1 shows 
the proteins identified only in the MyoA-GFP 
precipitate, by the presence of two or more 
specific peptides. This approach confirmed the 
presence of MTIP, GAP50, GAP45 and 
GAP40. It also identified GAPM2 and 
GAPM3, which are two of the three GAPM 
proteins previously shown to associate with 
the glideosome and IMC (20). The absence of 
GAPM1 in the precipitate could be explained 
by the extremely detergent-resistant property 
of this protein (20). In addition to these known 
or expected components of the glideosome, 13 
additional proteins were identified; whilst it is 
likely that some of them represent co-purified 
contaminants, it cannot be excluded that some 
represent real components of the complex. For 
example it is unlikely that signal peptide 
peptidase, MESA and the hexose transporter 
are part of the glideosome because of their 
known or predicted subcellular location: the 
endoplasmic reticulum (33), the parasite-
infected erythrocyte surface (34), and the 
parasite plasma membrane (35), respectively. 
On the other hand, the protein encoded by 
PF3D7_1420200 is a tetratricopeptide repeat 
protein related to TgUNC, demonstrated to be 
a member of the UCS family of myosin-
specific chaperones (15). In addition, of 
particular interest was the protein encoded by 
PF3D7_1017500, which is a 134 residue 
polypeptide with sequence homology to 
members of the EF-hand superfamily (36) and 
reminiscent of myosin light chains and other 
calmodulin-like proteins. This protein is a 
candidate second light chain for MyoA, 
particularly because it has been proposed that 
there is ‘space’ for a second light chain located 
adjacent to the MTIP binding site (37) and 
additional light chains have been characterised 
for MyoA in T. gondii (13, 14). Because of 
this, and data that will be shown below, we 
subsequently refer to PF3D7_1017500 as 
PfELC. 
 
Bioinformatic and functional analysis of 
PfELC, a novel P. falciparum MyoA light 
chain 
The ELC protein is highly conserved across 
the Plasmodium genus, with identities ranging 
from 59 % with P. berghei to 98 % with P. 
reichenowi (Fig. 5A), however there is only 
moderate sequence similarity with the T. 
gondii MyoA ELCs that have been described 
recently (13, 14). The Toxoplasma gene 
database, ToxoDB, has recently split the gene 
encoding TgELC1 into 2 genes—
TGME49_269438 and TGME49_269442 in 
the ME49 strain, erroneously in our opinion. 
Previous releases showed a single gene—
TGME49_069440—and it was using this 
release that Nebl and colleagues were able to 
assign peptides to TGME49_069440 from 
immunoprecipitates of the glideosome (13). 
Alignment of PfELC and TgELC1 
(TGME49_069440) proteins shows 20 % 
identity. Similarly, a second putative essential 
light chain, TgELC2 (TGME49_305050) that 
can bind to TgMyoA in place of TgELC1, 
shows 21 % identity with PfELC (Fig. 5B). 
Homology modelling using the Phyre2 
structure prediction server (38) suggested 
considerable structural similarity with 
calmodulin that is consistent with PfELC 
being a functional myosin light chain. The 
entire sequence was modelled on the structure 
of the calmodulin moiety of a genetically 
encoded calcium indicator protein (pdb ID: 
3U0K) with 76 % confidence (Fig. 5C). 
 
Interactions of PfELC with the glideosome 
and MyoA 
Several approaches were taken to obtain 
further information on the properties of 
PfELC. Antibodies were generated to the 
recombinant protein and used to test for the 
presence of the protein in immunoprecipitated 
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protein complexes from P. falciparum schizont 
lysates. The immunoprecipitate with GFP-
specific antibodies from cells expressing either 
MyoA-GFP or MyoB-GFP was probed with 
antibodies raised against recombinant PfELC. 
This analysis revealed a 14 kDa protein 
associated with MyoA in the glideosome 
complex, with very little free unbound protein, 
and none was detected associated with the 
MyoB complex (Fig. 5D). When the 
immunoprecipitation was performed with anti-
MTIP antibodies and a lysate of schizonts or 
merozoites from 3D7 parasites, western 
blotting with the PfELC-specific antibodies 
detected a 14 kDa protein in the complex, not 
only confirming the presence of PfELC but 
also demonstrating that it is present with MTIP 
in the same complex (Fig. 5E). 
PfELC was expressed in recombinant 
form as a His-tagged fusion protein (Fig. 6A). 
Far UV-CD spectra indicated that PfELC is 
mainly helical with 32 % alpha helix, 17 % 
beta sheet, and 20 % turn (Fig. 6Bi). The 
addition of 1 mM calcium ions had no effect 
on either the near- or far-UV spectrum 
suggesting that calcium does not bind to the 
protein, or that there is no change in secondary 
or tertiary structure of the protein upon 
binding. This is supported by the fact that 
there are no appropriately placed acidic 
residues that would normally be involved in 
the coordination of calcium ions in 
calmodulin-related proteins with canonical EF-
hands (39). To examine whether or not PfELC 
interacts directly with MyoA, the binding of 
the recombinant protein to peptides derived 
from the neck region of MyoA was examined. 
Amino acid residues 760 to 818 of MyoA 
constitute its neck region and MTIP has 
previously been shown to interact strongly 
with peptides from the C-terminus of the neck 
(40, 41). Using biolayer interferometry we 
measured the affinity of PfELC to overlapping 
biotinylated peptides corresponding to residues 
770–787, 786–803, and 801–818 of MyoA. 
There was no observable binding to peptide 
770–787, but both peptides 786–803 and 801–
818 bound to PfELC, with calculated Kds of 
0.48 [± 0.15] and 0.32 [± 0.07] µM 
respectively (Fig. 6C). There was no effect of 
1 mM calcium on the affinity to any of the 
three peptides. As MTIP has been shown to 
bind to the more distal MLC binding site, but 
not to a peptide representing residues 781–801 
of PfMyoA (41), we propose that PfELC binds 
to a region within 786–803, while MTIP binds 
to a region within 801–818 (Fig. 6D). 
 
The subcellular location of PfELC 
A parasite line expressing an HA-tagged 
PfELC was generated by single homologous 
recombination into the endogenous gene locus 
(Fig. 7A) and integration into the PfELC locus 
confirmed by PCR in two independent clones 
(Fig. 7B). The 17-kDa tagged protein could be 
detected by western blot analysis of parasite 
extracts and the time of synthesis 
corresponded to that of MTIP and GAP45 in 
mature schizonts, peaking at 44–46 h post-
invasion (Fig. 7C). By 48 h after invasion, 
many of the schizonts had ruptured and the 
merozoites gone on to invade fresh 
erythrocytes, explaining the apparent drop in 
expression of all glideosome components at 
this time point. Immunofluorescence analysis 
of fixed blood-stage P. falciparum with HA-
specific antibodies showed co-localisation of 
the protein with GAP45 and MTIP in late, 
segmented schizonts (Fig. 7B). 
 
Recombinant PfMyoA binds to actin 
As a first step to reconstitute the functional 
complex in vitro we expressed PfMyoA using 
an in vitro transcription/translation system and 
examined its ability to bind to actin.  Soluble 
GST-tagged PfMyoA was purified (Fig. 8A) 
and its ability to bind actin was examined 
using an optical tweezer-based single molecule 
system (Fig. 8B and C). A total of 244 acto-
MyoA binding events were recorded in 2 µM 
ATP, a concentration chosen based on the 
affinity of TgMyoA for 2'-/3'-O-
(N'methylanthraniloyl)-ADP (mant ADP (10). 
The MyoA working-stroke was 3 nm, as 
measured from the shift in mean position of 
the observed event distribution (Fig. 8D). 
Specificity of the acto-MyoA interaction was 
established using two different ATP 
concentrations of 0.3 µM and 8 µM and 
measuring the duration of acto-MyoA binding 
events fitted to a single exponential decay. The 
data were consistent with a single rate-limiting 
step, due to ATP binding to the acto-MyoA 
rigor complex. At 0.3 µM and 8 µM ATP we 
observed interactions lasting on average 0.1 s 
(Nobs=79) and 0.013 s (Nobs=165) respectively 
and consistent with Mg.ATP binding and 
dissociating the acto-MyoA rigor complex 
with second order kinetics of ~15 x 106 M-1.s-1 
(Fig. 8E).  
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MTIP and PfELC are required for maximum 
PfMyoA-dependent motility in vitro 
To examine the effects of light chain 
composition on MyoA motility, we expressed 
and purified recombinant MyoA together with 
MTIP and MTIP/PfELC. For these studies, we 
required more material than it was possible to 
generate using the in vitro 
transcription/translation system that we used in 
the single molecule PfMyoA studies described 
in the previous section. We opted for a 
heterologous expression system that would 
allow co-expression of PfMyoA and its light 
chains. Bookwalter and colleagues showed 
recently that TgMyoA can be expressed well 
in insect cells, but requires Unc45 to fold 
correctly (15). Therefore, we followed the 
same strategy and co-expressed the P. 
falciparum Unc45 homologue and PfHsp90 
together with PfMyoA, and were able to purify 
functional MyoA in complex with MTIP or 
with both MTIP and PfELC. Figure 9A shows 
size exclusion chromatography traces of the 
two purifications, indicating a pure, 
homogeneous complex. Fig. 9B shows the 
complexes separated by SDS-PAGE, 
indicating that the complexes contain the full 
complement of light chains included in the co-
expression system. A peculiarity is that MTIP 
migrates as two bands on the SDS-PAGE. We 
have performed mass spectrometry on each of 
the two bands to confirm they are both MTIP. 
We are unsure what is the cause of this 
aberrant migration. We studied MyoA 
complexes using an in vitro motility assay. 
MyoA was captured on a cover slip either by 
coating the surface with nitrocellulose (Fig. 
9C) or with an anti His-tag antibody (Fig. 9D), 
which orients the head domain away from the 
surface. Without addition of ATP, actin 
filaments bound to the surface and were non-
motile. Following ATP addition the filaments 
started moving, showing ATP-driven motility 
(supplemental movie file). We also observed 
significant actin filament fragmentation even 
at the lowest surface densities used that would 
still support smooth filament sliding motility 
(50 µg/ml myosin protein added to the flow-
cell surface). In our assay more than 95 % of 
actin filaments showed smooth gliding 
movement with only a small number of non-
moving filaments. This observation is firm 
evidence that our MyoA preparation contained 
very few so-called “dead-heads” (myosin 
“dead-heads” bind actin in an irreversible, 
tightly bound state). Nitrocellulose and 
antibody captured MyoA/MTIP gliding 
velocities were 0.13 ± 0.04 µm s-1 (Nobs=414), 
and 0.25 ± 0.06 µm s-1 (Nobs=761), 
respectively; showing antibody immobilization 
increased the gliding velocity approximately 
two-fold. Furthermore, the 
MyoA/PfELC/MTIP complex moved 
filaments approximately two-fold faster than 
the MyoA/MTIP complex and produced actin 
gliding velocities of 0.27 ± 0.06 µm s-1 
(Nobs=404) on nitrocellulose and 0.46 ± 
0.07 µm s-1 (Nobs=329) when immobilized via 
anti-His antibody. The maximum actin-
activated ATPase activity (Vmax) and actin 
affinity (Km) were 12.9 s-1 and 42 µM for 
MyoA/MTIP and 11.2 s-1 and 37 µM for 
MyoA/MTIP/PfELC, respectively (Fig. 9E). 
 
DISCUSSION 
We have taken advantage of the ability to 
GFP-tag MyoA to study in detail its time of 
synthesis and location in the life cycle of the 
malaria parasite, using fluorescence 
microscopy with live parasites expressing the 
tagged gene from the endogenous genomic 
locus. No growth phenotype was associated 
with the tagging of MyoA with GFP. The 
protein is most abundant in the invasive and 
motile stages. MyoA is an integral component 
of the glideosome complex, which is 
associated with the IMC located below the 
parasite plasma membrane. In the P. 
falciparum asexual blood stage there is no 
IMC in the ring and trophozoite stages, and 
genesis of the IMC commences soon after the 
onset of nuclear division, as part of the 
establishment of polarity for each developing 
merozoite and detected as intracellular ring-
shaped structures associated with the 
individual nuclei (28, 29). At this stage MyoA-
GFP cannot be detected in the cell. However, 
as the IMC continues to grow, leading 
eventually to cell segmentation and individual 
merozoite formation, MyoA accumulates on 
the IMC, which can be distinguished from the 
parasite plasma membrane in mature schizonts 
because it does not surround the food vacuole. 
In released extracellular merozoites, MyoA-
GFP has the characteristic peripheral location 
but then rapidly disappears following 
erythrocyte invasion. The mechanism by 
which the disappearance of the glideosome 
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occurs is undetermined. It is likely that 
proteasome-mediated degradation of the 
protein components occurs, though the 
signalling mechanisms that underlie this are 
unknown. Throughout the P. berghei life cycle 
MyoA is most abundant in the extracellular 
motile and invasive forms (merozoites, 
ookinetes and sporozoites). In the sexual 
stages although myoa mRNA is detected in 
gametocytes the protein is barely detectable in 
gametocytes or the zygote, and protein is only 
evident once ookinete differentiation is 
underway. Translational repression is a 
mechanism of post-transcriptional gene 
regulation in Plasmodium, and myoa has 
previously been shown to be regulated in this 
way (42, 43), with protein synthesis occurring 
after fertilisation. Following formation of the 
protuberance that heralds development of the 
polarised ookinete, MyoA-GFP begins to be 
deposited at the periphery of the growing 
protuberance through the retort forms until 
finally the entire mature motile ookinete is 
labelled with GFP fluorescence. The 
deposition of MyoA in this way provides 
insight into the formation of the IMC in the 
developing ookinete. It is possible that MyoA 
activity is important in providing the force 
required for the developing protuberance to 
extend away from the spherical body and 
acquire the characteristic shape of the 
ookinete. Similarly, the periphery of the 
salivary gland sporozoite is uniformly labelled 
with MyoA-GFP. Interestingly, the sporozoite 
was the only parasite stage in which we 
observed an additional perinuclear MyoA-GFP 
localization. It may be that the IMC plays a 
role in maintaining the shape of the sporozoite. 
A gene knockout in P. berghei of PbIMC1a, 
which encodes a sporozoite-specific protein 
with homology to articulins and localizes to 
the sporozoite IMC, resulted in salivary gland 
sporozoites with an abnormal morphology. 
The sporozoites had a characteristic bulge at 
the position of the nucleus, and the nucleus 
appeared more rounded than the usual slender 
nucleus of sporozoites (44). It is possible that 
MyoA plays a role in maintaining the cellular 
architecture and shape of the sporozoite in 
addition to its role in cell motility. The early 
cytomere stage of liver-stage parasites exhibits 
cytosolic MyoA-GFP fluorescence, with 
peripheral localization only detected in the 
late, segmented cytomere stage. It may be that 
in the early cytomere stage there is a pool of 
MyoA that is present prior to localization to 
the IMC in the late cytomere stage. 
The GFP-tag has also proved very 
useful to purify MyoA and associated proteins 
in P. falciparum. This approach confirmed the 
presence of MTIP, GAP45 and GAP50, 
identified previously by western blotting (26), 
and GAPM2 and 3—previously identified as 
components of the Apicomplexan glideosome 
(20). A third member of this family (GAPM1) 
was not detected here, likely because of its 
poor solubility in the detergent used. We also 
identified GAP40 as a component of the 
glideosome and confirmed that it is one of the 
major phosphorylated proteins in the complex. 
Although GAP40 has been described as a 
component of the T. gondii glideosome it has 
not previously been shown to be a component 
of this structure in Plasmodium. The fact that 
we only detected two peptides attributable to 
GAP40 (3.3 % sequence coverage) in our 
immunoprecipitation/mass spectrometry 
studies is likely due to the hydrophobic nature 
of this protein. GAP40 has ten predicted 
membrane-spanning regions, with very small 
loops between them. The two peptides we 
detected map to the short loop between 
predicted transmembrane domains 2 and 3. 
Hydrophobic peptides, such as those that 
would make up the majority of a GAP40 
tryptic digest, are often very poorly ionised in 
the mass spectrometry workflow, making 
detection very difficult. This could also 
explain why GAP40 has, until now, not been 
detected as a component of the Plasmodium 
glideosome. 
In addition to these known or expected 
components of the Plasmodium glideosome, 
several additional proteins were also 
identified. Whilst some such as the signal 
peptide peptidase or MESA are likely to be 
simple contaminants due to their known 
subcellular location, this cannot be said for 
some of the other proteins. Their presence or 
absence in complex with MyoA or other 
components of the glideosome complex needs 
to be examined in reciprocal 
immunoprecipitation experiments using, for 
example a variety of GFP-tagged proteins. The 
tetratricopeptide repeat-containing protein 
encoded by gene PF3D7_1420200 is similar in 
sequence to TgUNC in T. gondii 
(TGME49_249480), a member of the UCS 
family of myosin chaperones (15). Its presence 
in our immunoprecipitations supports a 
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conserved mechanism of myosin folding in a 
diverse range of organisms (45). Another of 
the proteins identified by mass spectrometry, 
coded by the gene PF3D7_1017500 and 
annotated as a conserved protein of unknown 
function, has a sequence suggesting that it 
might be a myosin light chain. It shows 
relatively weak homology with T. gondii 
ELCs, indicating that in this case it would not 
have been possible to identify the Plasmodium 
ELC by this criterion alone. Interestingly, the 
abundance of this protein—like that of other 
glideosome components including MyoA and 
MTIP—was significantly decreased in 
parasites blocked during schizont development 
(46). Unlike the situation in T. gondii 
tachyzoites, where two ELCs have been 
identified that bind to TgMyoA in a mutually 
exclusive manner (14), we found no evidence 
of light chains other than MTIP and ELC in 
our immunoprecipitations. This may indicate 
different modes of regulation and control of 
the glideosome in these species. Interestingly, 
there is redundancy in the ELCs of TgMyoA. 
Either of the genes encoding TgELC1 or 2 can 
be deleted with no effect on parasite viability, 
however deletion of both genes causes a 
marked reduction in the parasite’s ability to 
invade host cells (14). We have been unable to 
disrupt the elc gene in either P. berghei or P. 
falciparum, suggesting that the ELC is 
essential for parasite viability and that this 
redundancy does not exist in Plasmodium 
species. This is supported by the inability to 
disrupt Pbelc in the PlasmoGEM project 
(Plasmodb.org, RMgm-1936) (47). Utilizing 
approaches that are now available in P. 
falciparum, such as the expression of a Cre 
recombinase that dimerizes in response to the 
presence of a small molecule to rapidly and 
inducibly delete genes  (48), will be essential 
in order to further analyze the specific deficits 
that occur in parasite growth and development 
in the absence of PfELC. 
We tested the binding of PfELC to 
several peptides derived from the neck region 
of MyoA, which encompass the MTIP binding 
site at the C-terminus of the molecule and the 
adjacent putative light chain binding site 
previously identified by homology modelling 
(37). PfELC bound to both the known MTIP 
binding site and the adjacent proximal site. It 
has been shown previously that MTIP cannot 
bind to a peptide comprised of residues 781–
801 of the MyoA neck (41). This covers all of 
the sequence of peptide 786–801 used in these 
studies, which we have shown binds strongly 
to PfELC. These data, along with the co-
precipitation of PfELC with MTIP and MyoA 
from parasite lysates, confirm that MyoA is 
decorated with two light chains and that 
PfELC binds to sequences of MyoA adjacent 
to the MTIP binding site. A 30 amino acid 
region of the T. gondii MyoA neck (residues 
770–799) has been demonstrated to be the 
binding site for TgELC1 and 2 (14). The 
region of PfMyoA that we have demonstrated 
binds to PfELC is at the C-terminus of the 
equivalent region of PfMyoA, suggesting a 
similar arrangement of the two light chains on 
both TgMyoA and PfMyoA. We found no 
evidence of an effect of Ca2+ on the binding of 
PfELC to MyoA neck peptides or on the 
structure of PfELC itself, as judged by 
biolayer interferometry and circular dichroism, 
respectively. Studies in T. gondii have 
demonstrated Ca2+-binding by ELC1 and, by 
sequence homology it is assumed that TgELC2 
will also bind Ca2+. Specific amino acid 
residues have been suggested (D15, D17 and 
D19) or demonstrated (D15) to be required for 
Ca2+ coordination in TgELC1 (14). In the 
equivalent region of PfELC these residues are 
S17, C19, and D21 respectively. The sequence 
differences here support our observations that 
Ca2+ has no effect on the overall structure of 
PfELC or on its binding to PfMyoA neck 
peptides, in that the acidic residues required to 
coordinate Ca2+ in canonical EF-hand motifs 
(39) are absent. This suggests that there may 
be subtle differences in the regulation of ELC 
binding in the Plasmodium versus Toxoplasma 
glideosome. 
Additionally, we expressed and 
purified recombinant MyoA that bound to 
actin, and recombinant MyoA decorated with 
MTIP or MTIP/ELC that we used to measure 
sliding velocities by in vitro motility assays. 
The motility was induced by the addition of 
ATP, and only a small proportion of actin 
filaments were static, suggesting only a small 
fraction of non-functional or incorrectly folded 
myosin heads after a two-step purification. 
Importantly, MyoA with both MTIP and ELC 
bound had about a two times higher velocity in 
comparison to MyoA with MTIP alone. This 
suggests that ELC plays a significant role in 
Plasmodium motility. Our results are in line 
with results using TgMyoA, which moves 
actin with approximately two times higher 
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velocity when decorated by two light chains 
(15). It would be interesting to know whether 
the step size of the MyoA/MTIP/ELC complex 
is increased compared to that of the 
MyoA/MTIP complex, as this could be a 
possible explanation for the increased velocity 
that we observe in our motility studies for 
MyoA with its full complement of light chains. 
Since the actin-activated ATPase activity of 
MyoA/MTIP and MyoA/MTIP/PfELC was 
virtually identical, our conclusion is that the 
increased in vitro motility sliding velocity seen 
with MyoA/MTIP/PfELC compared to 
MyoA/MTIP alone cannot be explained by a 
change in catalytic turnover rate (ATPase 
activity). It is most easily explained by the 
MTIP/ELC light-chain combination having a 
longer effective lever arm and "working-
stroke" distance, meaning that actin is moved 
approximately twice as far for each molecule 
of ATP hydrolyzed. 
The glideosome is a molecular motor 
that has a key role throughout the parasite life 
cycle.  The key components of the glideosome 
for moving actin filaments are MyoA and its 
two associated light chains, and we have now 
established a system where the interplay and 
function of these three glideosome 
components can be studied.  This will also 
allow the development and assessment of 
inhibitors that target the glideosome function 
and block invasion of host cells. 
 
 
EXPERIMENTAL PROCEDURES 
Ethics statement for animal work 
Animal work at the University of Nottingham 
was approved by the local Animal Welfare and 
Ethical Review Body and by the United 
Kingdom Home Office under project licence 
numbers 40/3344 and 30/3248 in accordance 
with the United Kingdom Animals (Scientific 
Procedures) Act 1986 and in compliance with 
European Directive 86/609/EEC for the 
protection of animals used for experimental 
purposes. Six to eight-week-old female Tuck-
Ordinary (TO) outbred mice (Harlan) were 
used for these experiments.  
At the University of Bern experiments were 
conducted in strict accordance with the 
guidelines of the Swiss Tierschutzgesetz 
(TSchG; Animal Rights Laws) and approved 
by local authorities. The BALB/c mice used in 
these experiments were between 6 and 10 
weeks of age and bred in the central animal 
facility of the University of Bern. 
 
Analysis of PbMyoA gene expression by 
quantitative (q) RT-PCR. 
Blood stage P. berghei parasites from infected 
mice (day 4 post-infection) were cultured in 
vitro (49) and the following day schizont-
infected cells were purified on a 60 % v/v 
Nycodenz/PBS gradient. Gametocytes were 
purified on a 48 % (v/v) Nycodenz gradient, 
washed twice in RPMI 1640 medium and 
gamete formation activated by transfer to 
ookinete medium (RPMI 1640 containing 25 
mM HEPES, 25 % fetal bovine serum, 10 mM 
sodium bicarbonate, 50 mM xanthurenic acid 
at pH 7.6) for 30 min at 20 °C. For ookinete 
preparation, parasites from mice day 5 post-
infection were placed in ookinete medium for 
24 h at 20 °C, other parasite stages were lysed 
in red blood cell lysis buffer for 30 min and 
then ookinetes were purified on a 63 % 
Nycodenz gradient (v/v in PBS). On day 14 
post-feeding, mosquito guts were dissected 
and crushed in a loosely fitting homogeniser to 
release sporozoites, which were then 
quantified using a haemocytometer (50). 
Total RNA isolation, cDNA synthesis 
and PCR analysis were as described previously 
(49). Expression was determined using the 
Pfaffl method (51), using hsp70 
(PBANKA_0818900) and arginyl-tRNA 
synthetase (PBANKA_1434200) as reference 
genes. All primers sequences are available on 
request. 
 
Parasite genetic modification 
GFP-tagging of P. berghei genes 
P. berghei myoa (PBANKA_1355700) was 
modified by single homologous recombination 
to insert a sequence coding for a C-terminal 
GFP tag (Fig. 1B), using the p277 vector that 
contains a human dhfr selection cassette (52). 
An 833 bp region of Pbmyoa starting 1.86 kb 
downstream of the ATG start codon and 
omitting the stop codon was amplified using 
primers 7 and 8 and inserted into the vector 
using KpnI and ApaI restriction sites. The 
construct was linearized by digestion with PacI 
and used to transfect the P. berghei ANKA 
2.34 line by electroporation (53). The 
electroporated parasites were injected into 
naïve mice and transgenic parasites were 
selected with pyrimethamine (49) and 
analyzed by diagnostic PCR using the primers 
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9 and 10 to determine correct integration of the 
gfp sequence at the targeted locus (Fig. 1C). 
Western blotting with GFP-specific antibodies 
was used to confirm expression of full-length 
tagged protein of the predicted size (Fig. 1D).  
 
Tagging of P. falciparum genes 
P. falciparum (3D7) was cultured in RPMI 
1640 medium containing Albumax II 
according to previously described methods 
(54). GFP-tagging of P. falciparum MyoB, 
MyoA, and GAP45 has been described 
previously (26, 29). For HA-tagging of P. 
falciparum ELC at its C-terminus, a 632 bp 
DNA fragment of the gene was amplified 
using primers 11 and 12 and cloned via XmaI 
and AvrII sites into the pHH4-HA vector (E. 
Knuepfer, unpublished), a derivative of pHH1 
(55). 100 μg DNA was used to transfect ring-
stage P. falciparum as described previously 
(56). Transgenic lines were selected with 10 
nM WR99210 (a gift from Jacobus 
Pharmaceuticals). Plasmid integration was 
monitored by diagnostic PCR screening with 
primers 13 and 14 to detect the unmodified 
locus and primer pair 13 and 15 to detect 
integration (Fig. 7B). 
 
Antibodies 
Polyclonal rat anti-PfMyosin A antibodies 
were raised to a peptide of the sequence 
MVNKINELNNYFRINSTFINKSENE by 
Pepceuticals Ltd. according to their standard 
protocol. Mouse anti-PfELC antibodies were 
raised by immunisation of female BALB/c 
mice with recombinant His-tagged protein 
(production of which is described elsewhere in 
this manuscript). Other primary polyclonal 
antibodies and monoclonal antibodies (mAbs) 
used were anti-PfMTIP (40), anti-PfGAP45 
(18), anti-PfGAP50 (26) anti-PfRON4 mAb 
(57), and anti-PbP28 mAb 13.1 (58), which are 
described in the referenced manuscripts. 
Rabbit anti-GFP (Knuepfer and Holder, 
unpublished) and rat anti-HA (monoclonal 
3F10; Roche) antibodies were used to detect 
tagged proteins. Species-specific Alexa Fluor 
488 and 594 conjugated secondary antibodies 
were obtained from Molecular Probes (Life 
Technologies). 
 
Microscopy 
Live imaging of GFP-tagged parasite lines 
P. berghei asexual blood stage infections in 
mice were initiated by intraperitoneal (i.p.) 
injection of parasite-infected blood. The 
asexual, gametocyte and ookinete stages were 
observed using Hoechst 33342 dye (Molecular 
Probes) in ookinete medium and Cy3-
conjugated mouse mAb 13.1 to recognise the 
p28 protein on the surface of activated female 
gametes, zygotes and ookinetes. To examine 
mid-gut infection, guts were dissected 14 days 
after mosquito feeding on infected blood and 
mounted under Vaseline-rimmed cover slips 
after staining with Hoechst 33342 for 10–
15 min. On day 21 post-feeding, guts and 
salivary glands were dissected and crushed 
separately in a loosely fitting homogeniser to 
release sporozoites, which were then 
quantified using a haemocytometer and used 
for imaging. Microscopy was performed using 
a Zeiss AxioImager M2 microscope (Carl 
Zeiss, Inc.) fitted with an AxioCam MRm 
digital camera. P. berghei liver stage parasites 
were prepared and imaged as described 
previously (26), with the exception that 
infections were performed in HeLa cells. 
P. falciparum-infected red blood cells 
were prepared for live imaging as described 
previously (26, 29) and viewed using an Axio 
Imager M1 microscope (Zeiss).  
 
Indirect immunofluorescence assay 
Thin smears of parasites were fixed with 4 % 
paraformaldehyde for 30 min at room 
temperature. The fixed cells were 
permeabilized with PBS containing 0.1 % 
Triton X-100 for 5 min followed by blocking 
in 3 % BSA (w/v) in PBS at 4 °C overnight. 
Primary antibodies were diluted as required; 
species-specific Alexafluor-488 and 594 
conjugated secondary antibodies (Life 
Technologies) were used to visualize primary 
antibody binding. All antibody dilutions were 
carried out with 3 % BSA (w/v) in PBS. Slides 
were mounted for microscopic examination 
using Prolong Gold anti-fade reagent with 
DAPI (4',6-diamidino-2-phenylindole, Life 
Technologies). Slides were viewed using a 
Zeiss Axioplan 2 microscope, images captured 
using a Zeiss Axiocam MRc digital camera 
and Axiovision 4.8.2 software, and prepared 
for publication using Adobe Photoshop. 
To image stages of invasion of 
erythrocytes, tightly synchronized PfMyoA-
GFP-expressing late stage schizonts were 
mixed with erythrocytes and samples taken 
after 2, 5, 8, 10 and 30 min and fixed in 
solution with 4 % paraformaldehyde with 
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0.01 % glutaraldehyde for 60 min at room 
temperature. Further processing was carried 
out as described previously (59). 
 
Preparation of parasite lysates, 
immunoprecipitation of GFP-fusion 
proteins and analysis of the precipitates by 
western blotting and LC-MS/MS 
Parasite lysates 
Schizonts from MyoA-GFP, GAP45-GFP and 
3D7 P. falciparum parasite lines were first 
lysed in 0.15 % (w/v) saponin in PBS, 
harvested by centrifugation and then proteins 
were extracted using ten cell pellet volumes of 
ice-cold lysis buffer (0.5 % NP40, 150 mM 
NaCl, 10 mM Tris HCl pH 7.5, 1x Complete 
protease inhibitors [Roche]). Samples were 
cleared by centrifugation at 100,000 x g for 
10 min. The detergent concentration in the 
samples was reduced to 0.2 % by dilution with 
150 mM NaCl, 10 mM Tris pH 7.5, 
1x Complete protease inhibitors. 
For P. berghei, subcellular 
fractionation was performed as described 
previously (60). Briefly, cell pellets of MyoA-
GFP or WT-GFP schizonts were resuspended 
in hypotonic lysis buffer (10 mM Tris-HCl pH 
8.4, containing 5 mM EDTA and protease 
inhibitors), freeze/thawed twice and then 
incubated for 1 hr at 4°C. Following 
centrifugation at 100,000 g for 30 min, 
supernatant was collected as the soluble 
protein fraction (S). The remaining pellet was 
re-suspended in carbonate solution (0.1M 
Na2CO3, pH 11.0, containing protease 
inhibitors), incubated for 30 min at 4°C and 
then centrifuged at 100,000 g for 30 min. The 
resulting supernatant was classified as the 
peripheral membrane fraction (PM), and the 
pellet was washed and solubilised in 4% SDS 
and 0.5% Triton X-100 in PBS and classified 
as the integral membrane fraction (IM). Equal 
amounts of these three fractions were analyzed 
by western blot using anti-GFP antibody. 
 
Radiolabelling P. falciparum 
phosphoproteins 
P. falciparum schizonts (39 hours post-
invasion) were enriched by centrifugation 
through 70 % Percoll (GE Healthcare). The 
purified schizonts were washed twice with 
phosphate-free RPMI 1640 medium containing 
10 % human serum and incubated at 37 °C for 
30 min. Then, 25 MBq of 32P-phosphate 
(Perkin Elmer) was added to the culture and 
the incubation was continued for 2 h. The 
schizonts were then washed twice with serum-
free RPMI 1640 medium. The 32P-phosphate 
labelled schizonts were used for 
immunoprecipitation using the GFP-Trap 
system (Chromotek) as described below. 
 
Immunoprecipitation 
Parasite lysates were pre-cleared by incubation 
with blocked agarose beads for 1 h, then the 
supernatant was incubated with GFP-Trap 
agarose beads for 2 h at 4 °C with end-over-
end rotation. The beads were washed 
extensively with 150 mM NaCl, 10 mM Tris 
pH 7.5, then subjected to a further wash in 
300 mM NaCl, 10 mM Tris pH 7.5. Finally, 
the beads were resuspended in 5 volumes of 
2x SDS-PAGE sample buffer and boiled for 
5 min prior to fractionation of the proteins by 
SDS-PAGE. 
 
Western blotting 
Cell lysates were separated under reducing 
conditions on NuPAGE gels (Life 
Technologies). Proteins were transferred to 
nitrocellulose and blocked in 5 % w/v non-fat 
milk in PBS containing 0.2 % Tween-20. 
Primary antibodies were diluted in 5 % w/v 
non-fat milk in PBS containing 0.2 % Tween-
20. Species-specific horseradish peroxidase-
conjugated secondary antibodies (Biorad) were 
used and the signal developed using enhanced 
chemiluminescence (GE Healthcare). Blots 
were exposed to Biomax MR film (Kodak) 
and images prepared for publication using 
Adobe Photoshop. 
 
Protein identification by LC-MS/MS 
Proteins immunoprecipitated from GFP-
GAP45 parasite lysates were run on a 10 % 
NuPAGE BisTris gel (Life Technologies) and 
stained with SYPRO Ruby (Thermo 
Scientific). The protein bands were visualised 
using a Pharos FX Plus Molecular Imager and 
excised using EXQuest Spot Cutter (both 
Biorad). Proteins immunoprecipitated from 
MyoA-GFP or 3D7 parasite lysates were run 
4 mm into a 10 % NuPAGE BisTris gel (Life 
Technologies), then excised using a clean 
scalpel blade. In both cases proteins were 
reduced for 1 h in a solution of 20 mM DTT, 
200 mM ammonium bicarbonate (ABC), 50 % 
acetonitrile (ACN), and alkylated for 20 min in 
a solution of 5 mM iodoacetamide, 200 mM 
ABC, 50 % ACN, prior to overnight trypsin 
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digestion. The resulting digests were analyzed 
by LC-MS/MS using an Ultimate 3000 
nanoRSLC HPLC, equipped with a 50 cm x 
75 µm Acclaim Pepmap C18 column, coupled 
to an LTQ Orbitrap Velos Pro equipped with a 
Nanoflex electrospray source (all Thermo 
Scientific). A gradient of 6–32 % ACN/0.1 % 
formic acid over 48 min was used at a flow 
rate of 0.3 µl/min. The Orbitrap was operated 
in Data Dependent Acquisition mode with a 
survey scan at 60,000 resolution and up to the 
10 most intense ions selected for MS/MS. Raw 
files were processed using Proteome 
Discoverer (PD) 1.3 (Thermo Scientific) with 
Mascot 2.4 (Matrix Science, UK) as the search 
engine against the appropriate protein 
database. A decoy database of reversed 
sequences was used to filter the results at a 
false detection rate of 1 %. 
 
Bioinformatic analyses 
Alignment of ELC sequences was performed 
using CLC Sequence Viewer 6 (Qiagen) and 
graphics prepared using BoxShade. A 
structural model of PfELC was constructed 
using the Phyre 2 protein fold recognition 
server (38). Images were prepared using CCP4 
Molecular Graphics software (61). 
 
Cloning and expression of recombinant 
PfELC 
RNA was prepared from late P. falciparum 
parasites (approximately 36 h post-invasion) 
using TRIzol (Life Technologies) and cDNA 
made from this using the Reverse 
Transcription system with oligo dT primers 
(Promega). Primers 16 and 17 were used to 
amplify elc from cDNA, and the product was 
cloned into the pET46-Ek-LIC expression 
vector (Novagen) using ligation-independent 
cloning. After verification by sequencing, the 
plasmid was transformed into BL21 (DE3) 
cells (Stratagene), and protein expression 
induced by the addition of isopropyl β-D-1-
thiogalactopyranoside (IPTG) to 1 mM for 3 h 
at 37 °C. The cell pellet was lysed using 
Bugbuster (Novagen) with 25 U Benzonase/ml 
and 1x Complete Protease Inhibitors without 
EDTA (Roche). The lysate was cleared by 
centrifugation at 20,000 x g and was applied to 
a column of Ni-NTA agarose (Qiagen), 
followed by extensive washing of the column 
with 20 mM imidazole in phosphate buffer 
(GE Healthcare). The protein was eluted in 
three column-volumes phosphate buffer with 
0.5 M imidazole. The eluate containing the 
His-ELC protein was collected and 
concentrated using a Vivaspin 20 concentrator 
with a 5 kDa molecular weight cut-off 
(Sartorius). Buffer exchange into 50 mM 
NaCl, 10 mM Tris HCl, pH 8.0 was carried out 
using a PD10 column (GE Healthcare). 
 
Biophysical analysis of PfELC and its 
interaction with MyoA neck peptides 
Peptides 
Overlapping peptides representing amino acids 
Q770–A787, A786–S803, and I801–Q818 of 
the PfMyoA neck were synthesised by 
Mimotopes with biotin at the N-terminus. 
Each peptide had an SGSG linker between the 
biotin and 18 amino acids of the MyoA neck. 
The C-termini of the peptides were capped 
with an amide to remove unnatural charge, 
apart from peptide 801–818, which was left as 
a free acid. 
 
Far-UV CD 
Far-UV CD spectra were recorded on a Jasco 
J-815 spectropolarimeter fitted with a cell 
holder thermostatted by a CDF-426S Peltier 
unit. CD measurements were made at a protein 
concentration of 10 µM PfELC in 25 mM Tris 
HCl pH 8.0, 50 mM NaCl using fused silica 
cuvettes with 1 mm path length (Hellma). All 
spectra were recorded with 0.1 nm resolution 
and baseline corrected by subtraction of the 
buffer spectrum. Secondary structure content 
was estimated using methods described by 
Sreerama and Woody (62). 
 
Biolayer interferometry  
P. falciparum ELC binding to peptides was 
analyzed by biolayer interferometry using the 
Octet Red system (ForteBio) at 25 °C in 96-
well microplates, as described previously (63). 
All assays were performed in 100 mM Tris 
HCl pH 8.0 containing 0.005 % v/v Tween-20, 
according to the manufacturer’s instructions. A 
baseline was established over 4 min, and 
biotinylated peptides (0.4 µg/ml) were loaded 
onto streptavidin sensors for 10 min. The 
sensors were washed for 4 min and then 
incubated with PfELC at different 
concentrations (0.04–5 μM) for 800 s. The 
data were analyzed to calculate a dissociation 
constant (Kd) using non-linear regression with 
a one-site binding model and a least-squares fit 
(GraphPad Prism 6). 
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In vitro expression and purification of 
recombinant MyoA 
MyoA was expressed in a wheat germ cell free 
protein synthesis system (ENDEXT® 
Technology, CellFree Sciences) (64). 
Recombinant plasmid DNA using recodonized 
template DNA was amplified using specific 
primers and cloned into the vector pEU-E01G-
TEV-N1 to express N-terminal GST-tagged 
protein. For the in vitro transcription reaction, 
2 µg DNA was added to a transcription premix 
(11.5 µl nuclease free water, 1x transcription 
buffer, 2.5 mM NTP mix, 1 U/µl RNase 
inhibitor, 1 U/µl SP6 RNA Polymerase) in a 
total volume of 20 µl, and incubated at 37 °C 
for 6 h, according to the manufacturer’s 
instructions. The quality of mRNA produced 
was monitored by gel electrophoresis. The 
Bilayer Reaction System (CellFree Sciences) 
was used to translate mRNA into protein. 
mRNA (10 µl) was added to 10 µl of wheat 
germ extract (WEPRO® 1240) supplemented 
with 40 ng/µl creatine kinase, and carefully 
transferred directly below the SUB-AMIX 
solution (0.3 mM of each L-amino acid, 
100 mM potassium acetate, 2.7 mM 
magnesium acetate, 16 mM disodium creatine 
phosphate, 0.4 mM spermidine, 1.2 mM ATP, 
0.25 mM GTP, 4 mM dithiothreitol, and 
30 mM HEPES-KOH [pH 7.8]), and incubated 
for 20 h at 15-16 °C. Soluble GST-tagged 
MyoA was purified using glutathione 
sepharose beads (GE Healthcare); supernatant 
was incubated with the resin for 2 h at 4 °C, 
followed by extensive washing with 20 mM 
Tris HCl pH 8.0, 250 mM NaCl, 0.5 mM 
TCEP. The beads were resuspended in 
3 volumes 20 mM Tris HCl pH 8.0, 100 mM 
NaCl, 10 mM reduced glutathione in order to 
elute the GST-tagged protein. This was 
followed by buffer exchange into PBS on a 
PD10 column (GE Healthcare). 
 
Single molecule optical tweezer studies to 
examine the MyoA interaction with actin  
The optical tweezer (OT) assay, developed to 
measure the force and movement produced by 
individual myosin molecules interacting with 
an actin filament, was used in the well-
established three bead format with the 
experimental conditions as described (65-67). 
The experimental apparatus is based around a 
Zeiss inverted microscope and experiments 
were performed in a flow-cell chamber created 
using a microscope slide and cover-slip. The 
solution buffers and other conditions were 
identical to those used in earlier studies (67). 
A single, rhodamine-phalloidin labelled, actin 
filament, comprising 1:5 biotin-labelled actin 
to plain actin, was captured between two 
neutravidin-coated beads (~1 µm diameter) 
using the dual-beam optical tweezers. A third, 
surface-immobilised bead that was sparsely 
coated with MyoA was then positioned in 
close proximity to the actin filament. 
Interactions between the surface-bound MyoA 
and the actin filament were recorded by 
monitoring movement of the beads held in the 
optical tweezers using two 4-quadrant, 
photodiode detectors. To facilitate 
visualization, the beads were moved 
backwards and forwards using a 100 nm 
amplitude, 10 Hz triangular wave. Individual 
events were then automatically detected by 
measuring changes in amplitude of the 
imposed triangular oscillation and event 
amplitudes were histogrammed. Data were 
acquired and saved to computer memory using 
custom software, with a sampling rate of 
10 kHz, and later analyzed using IgorPro 
software (WaveMetrics Inc., Lake Oswego, 
Or, USA). Individual acto-MyoA force-
producing events were identified as described 
previously (65) and the MyoA power stroke 
amplitude and kinetics were analyzed by 
histogram analysis of the data. 
 
Expression in insect cells and purification of 
recombinant MyoA with light chains  
Following the example of Bookwalter et al. 
(15), we co-expressed PfHsp90 and Unc45 
chaperones together with full-length MyoA, 
PfELC and MTIP in Sf21 cells. By sequence 
homology, PF3D7_1420200 is the P. 
falciparum orthologue of Toxoplasma Unc45 
(PlasmoDB.org). Codon-optimised genes were 
designed and synthesised (Life Technologies) 
for insect cell expression. A codon-optimised 
Hsp90 (PF3D7_0708400) was a kind gift from 
Dr. Will Stanley. PfUnc45 was cloned under 
the polyhedrin promoter in the pFL vector (68) 
and Hsp90 under the control of p10 promoter 
in the same vector. MyoA (PF3D7_1342600) 
was cloned into the pFL vector and fused with 
N-terminal StrepTagII and gfp under the 
polyhedrin promoter. MTIP (PF3D7_1246400) 
and ELC (PF3D7_1017500) genes were 
 at LO
N
D
O
N
 SCH
 O
F H
Y
G
IEN
E &
 TRO
PICA
L M
ED
ICIN
E on Septem
ber 20, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
15 
 
cloned into the pFL vectors under the control 
of the polyhedrin promoter with N-terminal 
hexa-histidine tags. Each construct was 
transformed in MAX Efficiency DH10Bac 
cells (Invitrogen), bacmids were isolated, and 
the gene integrations were confirmed using 
standard protocols (Bac-to-Bac, Invitrogen). 
Sf21 cells (Gibco) were transfected using 
FuGene 6 (Promega) as described (69). After 
two rounds of virus amplification, Sf21 cells 
were co-infected with untitered recombinant 
viruses in the ratios of 0.75:1:1:1 for 
MyoA:Unc45:MTIP:ELC or 0.75:1:1 for 
MyoA:Unc45:MTIP, and harvested cells 3 
days post-infection. We used 1.5 ml of MyoA-
expressing virus per 1 x 108 cells, the others 2 
ml per 1 x 108 cells. Cells were collected, 
washed with PBS, resuspended in the lysis 
buffer (20 mM Hepes pH 7.5, 5 % trehalose-
dihydrate (w/v), 1 mM ATP, 0.5 mM TCEP, 
2.5 mM MgCl2, 0.5 mg avidin, 1X SigmaFast 
EDTA free protease inhibitor), sonicated, and 
clarified at 38,000 g. Remaining supernatant 
was applied into two inter-connected 1 ml 
Strep-Tactin superflow columns (IBA GmbH), 
washed with lysis buffer,  washing buffer 1 
(20 mM Hepes pH 7.5, 5 % trehalose-
dihydrate(w/v), 150 mM KCl, 0.5 mM TCEP), 
and washing buffer 2 (20 mM Hepes pH 7.5, 
5 % trehalose-dihydrate(w/v), 0.5 mM TCEP). 
MyoA complexes were eluted with 20 mM 
Hepes pH 7.5, 5 % trehalose-dihydrate (w/v), 
0.5 mM TCEP, and 3.5 mM D-desthiobiotin. 
MyoA/light chain(s) containing fractions were 
pooled, concentrated, and run over a Superdex 
200 increase 10/300GL column (GE 
Healthcare) in washing buffer 2. After a size 
exclusion step, fractions containing 
MyoA/light chain complexes were pooled, 
concentrated, snap-frozen in liquid N2, and 
stored at <-76°C until use. 
 
In vitro motility assays 
Motility assays were essentially performed as 
in Butt et al. (70). Our assay buffer, AB 
(25 mM imidazole-HCl, 25 mM KCl, 1 mM 
EGTA, 4 mM MgCl2 pH 7.4) was repeatedly 
degassed, and flushed with argon and stored in 
a hypodermic syringe to prevent oxygen 
contamination. An oxygen scavenger, COG, 
(20 mM DTT, 0.2 mg/ml glucose oxidase, 
0.5 mg/ml catalase, 3 mg/ml glucose, 
0.5 mg/ml BSA) was added to buffers used 
during fluorescence imaging, and stored at 
room temperature during experiments. 
Microscope flow-cell chambers were 
constructed using double-sided tape (Tesa), 
and flow-cell volume was approximately 8–12 
µl. To capture MyoA/light chain complexes by 
anti-His antibody, nitrocellulose-coated cover-
slips were incubated with neutravidin (Thermo 
Fisher Scientific) for 4 min. The flow-chamber 
was then washed four times with buffer AB 
and then blocked (2x) with AB/BSA (AB with 
0.5 mg/ml BSA) for 2 min. Biotinylated anti-
His antibody (Qiagen) was diluted 1:5 in 
AB/BSA, and applied into the flow cell for 
4 min. The non-bound antibodies were 
removed by washing twice with AB/BSA, and 
MyoA complexes were applied for 2 min, 
before washing the flow cell twice with 
AB/BSA, and applying rhodamine-phalloidin 
labelled F-actin in AB/COG for 2 min. We 
used MyoA/MTIP and MyoA/MTIP/PfELC at 
concentrations of 0.25 and 0.27 mg/ml for 
nitrocellulose capture, and 0.11 and 0.05 
mg/ml for anti His-tag capture, respectively. 
The flow-cell was washed twice with 
AB/COG and then viewed by fluorescence 
microscopy. Assays were performed using an 
Axioskop 40 fluorescence microscope with a 
Zeiss PlanNeofluar 100x 1.3 NA objective 
lens. Fluorescence was excited by a mercury 
arc lamp using a rhodamine filter 
set (Excitation filter HQ535/50, dichroic 
mirror Q565LP and emission filter HQ605/75; 
Chroma technology) and light emitted from 
the rhodamine-phalloidin labelled actin 
filaments specimen was imaged onto an 
image-intensified charge-coupled device 
camera (IC-310 Photon Technology 
International) where, at the magnification 
used, each pixel corresponded to 100 nm at the 
object plane. Sequences of video frames were 
captured every 40 ms using a frame grabber 
card (Multipix Imaging Ltd). The laboratory 
was air-conditioned and the experimental 
temperature kept at 23 °C. Filament specimens 
were tracked automatically with GMimPro 
(71) using non-default settings Q-threshold 3, 
and track length 5, after saving each image 
sequence as a median of five consecutive 
image blocks. Non-motile or short tracks were 
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removed manually. From resulting average 
velocities, frequency distribution histograms 
were calculated (a bin size of 0.02) and a 
Gaussian curve was fitted with GraphPad 
Prism 7. 
 
Actin-activated ATPase assay  
The actin-activated ATPase of MyoA/MTIP 
and MyoA/MTIP/PfELC was estimated using 
an NADH-coupled assay to quantify the rate 
of ATP hydrolysis. The assay buffer contained 
160 U/ml lactate dehydrogenase, 400 U/ml 
pyruvate kinase, 1 mM phospho(enol) 
pyruvate, 0.5 mM ATP and 0.3 mM NADH in 
the motility assay buffer, AB. The myosins 
(MyoA/MTIP or MyoA/MTIP/PfELC) were 
added to a final concentration of 0.13 µM and 
phalloidin-stabilized filamentous actin was 
added over the range of 7 to 130 µM. The rate 
of ATP hydrolysis was calculated from the 
rate of change in NADH absorbance measured 
in a temperature-controlled spectrophotometer 
at 340nm. Experiments were conducted at 23 
oC. The data were fit to the Michaelis-Menten 
equation using non-linear regression with a 
least squares fit in GraphPad Prism. 
 
Primers 
Sequences of primers used in these studies are 
available on request. 
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Table 1. Identification of proteins immunoprecipitated by GFP-TRAP affinity resin together 
with P. falciparum MyoA-GFP using mass spectrometry.  
All proteins were absent from a control P. falciparum immunoprecipitation where MyoA was 
unmodified. Proteins are ranked by the percentage sequence coverage and previously known 
components of the glideosome/IMC are shaded grey. 
 
Accession number Protein description MW [kDa] Coverage [%] Peptides 
PF3D7_1342600 myosin A (MyoA) 92.2 72.5 66 
PF3D7_1246400 myosin light chain 1, myosin A tail domain interacting protein (MTIP) 23.5 31.4 7 
PF3D7_0918000 glideosome-associated protein 50 (GAP50) 44.6 29.8 9 
PF3D7_1017500 conserved Plasmodium protein, unknown function 15.7 24.6 2 
PF3D7_1033200 early transcribed membrane protein 10.2 (ETRAMP 10.2) 38.9 22.8 6 
PF3D7_1222700 glideosome-associated protein 45 (GAP45) 23.6 19.6 4 
PF3D7_0822900 conserved Plasmodium protein, unknown function 138.2 16.2 15 
PF3D7_1444300 putative 1-acyl-sn-glycerol-3-phosphate acyltransferase 33.7 12.7 2 
PF3D7_0423500 glideosome-associated protein with multiple membrane spans 2 (GAPM2) 42.6 12.4 2 
PF3D7_1416100 putative GTP-binding protein, root hair defective 3 (RHD3) homologue 110.5 12.2 10 
PF3D7_1409400 conserved Plasmodium protein, unknown function 30.5 10.7 5 
PF3D7_1032500 putative DER1-like protein, (Der1-2) 31.0 10.3 3 
PF3D7_1457000 signal peptide peptidase (SPP) 47.5 8.0 3 
PF3D7_0515700 putative glideosome-associated protein 40 (GAP40) 51.8 7.5 4 
PF3D7_0500800 mature parasite-infected erythrocyte surface antigen, protein 2 (MESA) 168.2 6.9 6 
PF3D7_1406800 glideosome-associated protein with multiple membrane spans 3 (GAPM3) 32.9 6.7 2 
PF3D7_0912400 alkaline phosphatase 52.7 5.8 2 
PF3D7_0204700 hexose transporter (HT) 56.4 5.4 2 
PF3D7_0824400 nucleoside transporter 2 (NT2) 67.6 3.8 2 
PF3D7_1420200 tetratricopeptide repeat family protein, putative 147.9 1.9 2 
 
  
 at LO
N
D
O
N
 SCH
 O
F H
Y
G
IEN
E &
 TRO
PICA
L M
ED
ICIN
E on Septem
ber 20, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
23 
 
Figure 1. Expression of GFP-tagged MyoA through the P. berghei life cycle. (A) Transcription of 
myoa analyzed by qRT-PCR normalised against two control genes, hsp70 and arginine-tRNA 
synthetase at different stages of the life cycle. The mean normalized myoa expression is shown as a 
horizontal bar and standard deviations are indicated by error bars. AS: asynchronous asexual blood 
stages, Sch: schizonts, NAG: non-activated gametocytes, AG: activated gametocytes, Ook: ookinetes, 
and Spor: sporozoites. (B) A plasmid containing the sequence for the 3’ end of the MyoA coding 
region fused in frame to the gfp sequence, together with a human dhfr selectable marker, was used to 
insert the gfp sequence into the endogenous myoa gene. (C) Successful integration into the P. berghei 
genome was confirmed by diagnostic PCR on genomic DNA prepared from wild type parasites and 
those with integrated plasmid sequence using primers 9 and 10, which amplify a 1.1 kb DNA 
fragment from the modified myoa locus following correct integration. (D) Expression of the GFP-
tagged MyoA was confirmed by western blotting of lysates from parasites expressing either the 
unfused GFP or the MyoA-GFP proteins; as indicated GFP-specific antibodies reacted with either a 
29 kDa or a 120 kDa protein, respectively. (E) Extracts of schizonts following hypotonic lysis in the 
soluble fraction (S) and further fractionation of the insoluble material by carbonate buffer into 
carbonate-soluble (PM, peripheral membrane) and insoluble (IM, integral membrane) fractions. 
Schizonts from parasites expressing either GFP (upper row) or MyoA-GFP (lower row) were used. 
(F) Expression of MyoA-GFP at the invasive and motile stages of the parasite life cycle, detected by 
live fluorescence microscopy. The parasite nuclei are stained with Hoechst 33342 and the ookinete 
surface with Cy3-conjugated anti-P28 antibody 13.1. In the merged colour image these are blue and 
red respectively, and the MyoA-GFP is green. The differential interference contrast (DIC) bright field 
images are also shown. Scale bar: 5 µm. (G) Expression of MyoA-GFP in liver stage parasites at the 
early and late cytomere stages; GFP fluorescence (green) and Hoechst 33342 staining (blue). Scale 
bar: 10 µm. (H) Temporal profile of MyoA-GFP expression during the six stages of Plasmodium 
berghei ookinete development. MyoA-GFP was detected by live fluorescence microscopy associated 
with the protuberance that grows out of the spherical body only at stage III and eventually forming the 
motile ookinete. The parasites were co-stained with Hoechst 33342 and with Cy 3-conjugated anti-
P28 antibody 13.1 as a marker for the zygote and ookinete surface. The merged (MyoA-GFP:green; 
P28: red; Hoechst: blue) and differential interference contrast (DIC) bright field images are also 
shown. Scale bar: 5 µm. 
 
Figure 2. MyoA-GFP expression and glideosome complex formation during the late stages of 
intracellular development of P. falciparum in the red blood cell. (A) MyoA-GFP expression was 
detected by live fluorescence microscopy and the nuclei were detected by staining with DAPI. The 
merged colour image with MyoA-GFP (green) and DAPI (blue) and differential interference contrast 
(DIC) bright field images are also shown. Schizogony starts at around 30 hours post-invasion and 
MyoA-GFP is detected from 38–40 hours in multinucleated forms. Scale bar: 2 µm. (B) Parasites 
expressing MyoA-GFP were collected at indicated time points post-invasion and lysates prepared; 
samples of these lysates (upper panel) and of proteins precipitated from them with a GFP-specific 
antibody (lower panel) were fractionated by SDS-PAGE and probed on western blots with antibodies 
to GFP, MTIP, GAP45 and GAP50. Molecular weight markers are indicated in kDa. 
 
Figure 3. The location of MyoA during P. falciparum merozoite invasion. (A) MyoA-GFP is located 
at the periphery of developing intracellular (top row of each pair of images) and free extracellular 
merozoites (bottom row), and is colocalized with antibodies specific for IMC proteins MTIP, GAP45 
and GAP50. In the merged colour image the MyoA-GFP signal is green and antibodies specific for 
the IMC proteins are red; nuclei are stained blue with DAPI. The DIC image is also shown. (B) 
Individual merozoites are captured at different stages of invasion from initial attachment, through 
early and late invasion to the intracellular ring stage. MyoA-GFP remains peripheral whereas RON4, 
initially in the apical rhoptry neck, relocates during invasion. Merged colour images with MyoA-GFP 
(green), RON4 (red), and nuclei (blue) and DIC images are also shown, together with a schematic of 
each cell-pair. Scale bar: 2 µm. 
 
Figure 4. Identification of GAP40 in the P. falciparum glideosome complex. (A) Wild-type (lane 1) 
or GAP45-GFP expressing (lane 2) P. falciparum 3D7 parasites were incubated with radiolabelled 
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phosphate and proteins binding to a GFP-specific antibody were immunoprecipitated, resolved on a 
SDS-PAGE gel and detected by autoradiography. Bands corresponding to two unidentified proteins 
are labelled with one or two asterisks. In parallel the same samples were probed with antibodies to 
known components of the glideosome complex: MyoA, GAP45, GAP50 and MTIP. (B) The 
immunoprecipitation with anti-GFP antibody resin was repeated with unlabelled schizont lysate from 
wild-type (lane 1) or GAP45-GFP expressing (lane 2) P. falciparum 3D7 parasites. 
Immunoprecipitated proteins were fractionated by SDS-PAGE, detected with SYPRO Ruby and the 
indicated bands were excised. (C) Proteins identified in the three excised bands by tryptic digestion 
and mass spectrometry. The number of unique peptides identified for each protein is indicated, along 
with the percentage of the protein sequence that these peptides cover. 
 
Figure 5. The putative ELC binds to MyoA but not MyoB and is in the P. falciparum glideosome 
complex together with MTIP. Alignment of (A) Plasmodium ELC homologues, and (B) PfELC with 
the two T. gondii MyoA ELCs. Identical residues are shaded black, biochemically similar residues are 
shaded grey. Percentage identities to PfELC are displayed. Gene identifiers are as follows: PfELC: 
PF3D7_1017500; PrELC: P. reichenowi PRCDC_1016900; PvELC: P. vivax PVX_001745; PcyELC: 
P. cynomolgi PCYB_061180; PkELC: P. knowlesi PKNH_0601700; PcELC: P. chabaudi 
PCHAS_0501900; PyELC: P. yoelii PY02639; PbELC: P. berghei PBANKA_0501800; TgELC1: T. 
gondii TGME49_069440; TgELC2: T. gondii TGME49_305050. (C) Structural homology model of 
ELC generated using Phyre 2. (D) Proteins in extracts from wild type (3D7) schizonts and those 
expressing either MyoA-GFP or MyoB-GFP were immunoprecipitated with resin-bound antibodies to 
GFP, and then probed by western blotting with antibodies to GFP and ELC. I: input lysate, U: 
unbound protein, E: protein eluted from the resin. (E) The protein complex containing MTIP also 
contains ELC. The glideosome complex from lysates of schizonts (S) and merozoites (M) of 3D7 was 
precipitated with anti-MTIP antibodies, resolved by SDS-PAGE and the presence of ELC was 
determined by western blot with specific antibodies. A pre-immune antibody sample was used to 
immunoprecipitate from the lysates as a control. 
 
Figure 6. The putative MyoA ELC binds to the neck region of MyoA. (A) Purification of 
recombinant His-PfELC protein. (Bi) Far- and (ii) near-UV circular dichroism spectra of recombinant 
protein indicate that it is highly structured, with 32 % alpha helix, 17 % beta sheet, 20 % turn. (C) 
PfELC binding to immobilised peptides corresponding to residues 770–787, 786–803 and 801–818 of 
MyoA was measured by biolayer interferometry, using increasing concentrations of PfELC. The 
dissociation constant (Kd) with standard error was calculated from each of the curves. (D) The amino 
acid sequence of the neck region of MyoA, showing the location of the peptides used for analysis, the 
MTIP binding site, and the proposed ELC binding site. 
 
Figure 7. PfELC expression matches that of known glideosome components in P. falciparum 
schizonts. (A) Scheme for modifying the PF3D7_1017500 gene locus by single crossover 
homologous recombination in order to C-terminally modify the ELC protein with a triple-HA tag. (B) 
PCR screening of parental 3D7 parasites and two independently generated clones. PCR product from 
the wild-type locus was amplified using primers 13 and 14 (WT), while a product (I) from the 
modified locus was amplified using primers 13 and 15. (C) Western blot analysis of HA-tagged ELC, 
MTIP and GAP45 proteins present during a time course of schizont development. (D) 
Immunofluorescent detection of HA-tagged ELC and either MTIP or GAP45 in mature schizonts and 
merozoites. Merged colour images are also shown, with ELC-HA (green) and MTIP or GAP45 (red). 
Nuclei are stained with DAPI (blue). Scale bar: 2 µm. 
 
Figure 8. Recombinant MyoA binds actin. (A) Coomassie-stained SDS-PAGE showing affinity 
purified GST-MyoA, marked with an asterisk. (B) An actomyosin event as determined using optical 
tweezers, with an actin filament held between 2 beads: a left-hand bead (blue) and a right-hand bead 
(red); with the MyoA molecule on a third bead. Because of the high-sensitivity required in these 
single molecule measurements, Brownian motion causes a significant amount of displacement noise 
and when MyoA binds to actin that event is evident by a sudden decrease in the standard deviation of 
the displacement noise (shown in black). Events are scored by thresholding data falling below a fixed 
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value (dotted red/blue line). Note: movement of the left-hand bead and its standard deviation are 
offset by -200 nm and -30 nm, respectively, for clarity. (C) Improved visualisation of binding events 
is achieved by moving the beads back-and-forth using a 10 Hz triangular wave function of 100 nm 
amplitude. (D) Displacement histogram generated from 244 acto-MyoA binding events with a fitted 
Gaussian distribution. The magnitude of the displacement (nm) is displayed on the x-axis and the 
number of observations at that value (Nobs) on the y-axis. The average movement caused by the 
myosin “power-stroke” was measured as 3 nm. (E) Acto-MyoA event lifetime distributions measured 
at two Mg.ATP concentrations, 8 µM (blue symbols) and 0.3 µM (red symbols), confirm that the 
event lifetimes are strongly dependent on [Mg.ATP]. The x-axis shows the duration of the binding 
event (in seconds); the y-axis, is the number of observations (Nobs) at that value. The lines are single 
exponential least-squares fits with rate constants 53 s-1 (blue) and 6.9 s-1 (red). 
 
Figure 9. MTIP/ELC decorated MyoA shows increased in vitro sliding motility. (A) Size exclusion 
chromatography of co-expressed MyoA and MTIP (solid line) and MyoA, MTIP and ELC (dotted 
line) (B) Coomassie-stained SDS-PAGE of the purified MyoA-light chain complexes. (C) Motility of 
nitrocellulose-captured MyoA complexes, and (D) the corresponding capture of MyoA complexes via 
an anti His-tag antibody measuring the velocity of actin filament movement in the presence of ATP. A 
solid line represents a Gaussian fit to each corresponding histogram. (E) The actin-activated ATPase 
of MyoA/MTIP and MyoA/MTIP/PfELC was estimated using an NADH-coupled assay to quantify 
the rate of ATP hydrolysis. 
 
Supplemental movie. The four panels show the movement of fluorescent actin filaments by 
MyoA/MTIP bound by nitrocellulose (top left panel) or by anti-His antibody (lower left panel), and 
MyoA/MTIP/ELC bound by nitrocellulose (top right panel) or by anti-His antibody (lower right 
panel).  
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
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Figure 9 
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